Methods: We conducted a retrospective cohort study that included 57 patients with EGPA without proteinase 3-ANCA positivity who fulfilled the 2022 ACR/EULAR classification criteria. This evidence concerns the gene PRTN3 and eosinophilic granulomatosis with polyangiitis.